EPISODE · Apr 1, 2026 · 3 MIN
2026 Alert: Samsung's FDA-Approved Blood Pressure Watch Reshapes Market
from Signal Daily: Enterprise Tech Strategy · host Signal Daily News
[object Object]
What this episode covers
Samsung's FDA-approved blood pressure monitoring on Galaxy Watches disrupts the $10.5B wearable market. But the real shift isn't in tech—it's how this pressures Apple and reshapes competitive dynamics.
NOW PLAYING
2026 Alert: Samsung's FDA-Approved Blood Pressure Watch Reshapes Market
No transcript for this episode yet
Similar Episodes
Feb 1, 2025 ·168m
Aug 7, 2024 ·58m